USD 2.37 billion
Report ID:
SQMIG35J2083 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
64
|Figures:
75
Global Thyroid Gland Disorders Treatment Market size was valued at USD 2.37 billion in 2022 and is poised to grow from USD 2.45 billion in 2023 to USD 3.14 billion by 2031, growing at a CAGR of 3.17% in the forecast period (2024-2031).
The global thyroid gland disorders treatment market has grown significantly in the last several years. This is explained by the fact that thyroid conditions such as hyperthyroidism are becoming more commonplace throughout the world. This market has grown as a result of expanding aging populations, improved medical technology, and growing awareness of the value of early diagnosis and treatment.
New customized medicine techniques and novel medicines targeting particular thyroid problems have entered the market. Due to higher rates of thyroid problems and higher healthcare costs, North America and Europe now control the majority of this market.
However, because of improved healthcare infrastructure and growing awareness, emerging economies in Latin America and Asia-Pacific are demonstrating significant development potential. To summarize, the global thyroid gland disorders treatment market is seeing expansion due to factors such as rising illness prevalence, developments in technology, and an increase in treatment options.
The therapy of thyroid problems was among the healthcare areas where telemedicine and remote monitoring solutions were becoming more and more popular. Telehealth services were being used by patients more frequently for endocrinology consultations, medication management, and routine check-ups. The ease of remote healthcare access, particularly in places with little access to specialist thyroid care, was the driving force behind this movement.
The climbing growth rate of the global thyroid gland disorders treatment market can falter due to some problems. Limited diagnostic facilities and awareness of this specific treatment and the high cost of such therapies can pose a threat to market expansion. However, the projected growth of this market indicates that this industry will persevere.
Global Market Size
USD 2.37 billion
Largest Segment
Thyroidectomy
Fastest Growth
Radioiodine therapy
Growth Rate
3.17% CAGR
To get more reports on the above market click here to Buy The Report
Market segmentation based on treatment methods includes medication, radioiodine therapy, thyroidectomy, and alternative therapies. When the market is divided based on end-users, it includes hospitals, clinics, and retail pharmacies. Geographically, the market can be divided into North America, Europe, Asia-Pacific, and the rest of the world.
Analysis By Treatment Method
The medication segment is typically the largest in the thyroid gland disorders treatment market. Levothyroxine and other thyroid medications are widely prescribed, and the market for these drugs is quite substantial. It is relatively stable and tends to grow steadily due to the increasing prevalence of thyroid disorders.
The radioactive Iodine therapy segment, while smaller than the medication segment, has shown stable growth, primarily due to its effectiveness in treating hyperthyroidism. As awareness of this treatment option increases, it may continue to grow. The Thyroid Surgery segment is more specialized and is typically smaller than the medication and radioactive iodine therapy segments. However, it may experience growth due to advancements in surgical techniques and an increasing number of thyroid cancer cases being diagnosed.
Analysis By End-user
When it comes to end-users, hospitals and clinics hold the largest share of the thyroid gland disorders treatment market. These outlets are favored due to one primary reason. That is because it is equipped to manage multiple thyroid conditions. Hospitals and clinics can cover long-term and short-terms treatments, diagnosis, consultation, and more.
Though hospitals and clinics rule the market, diagnostic labs are witnessing a period of rapid growth. The knowledge and awareness of thyroid issues has grown, highlighting the importance of an accurate and early diagnosis. This has fueled the need for diagnostic services, thus leading to this segment’s explosive growth. Other factors that have led to the expansion of this segment, and the overall market, include the improvements in telemedicine and development of homecare testing kits.
To get detailed analysis on other segments, Request For Free Sample Report
North America, particularly the US, holds the largest market share. This is because thyroid disorders are widely common in the region. Another reason for North America’s dominance is its developed and thriving pharmaceutical and healthcare system.
Though North America holds the top position in the market for the treatment of thyroid gland problems, there is another region which is climbing the market ladder quickly. That region is the Asia-Pacific (APAC). Its growth rate is specifically focused in China and India. The reasons for its explosive growth are the changing lifestyles of the APAC population, along with a growing population and increasing costs of healthcare.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drivers
Increasing Prevalence of Thyroid Disorders
Treatment Advancements and Options
Restraints
High Cost of Thyroid Medications and Treatment
Limited Diagnostic Facilities and Awareness
Request Free Customization of this report to help us to meet your business objectives.
A variety of pharmaceutical and biotechnology companies are engaged in a fierce competition in the global thyroid gland disorders treatment market as they strive to develop innovative medications to grab a large piece of the market and address a diverse range of thyroid conditions. Industry leaders like Mylan N.V., Pfizer Inc., AbbVie Inc., and Merck KGaA, utilize their resources for extensive R&D in order to launch new medications and formulations. Diagnostic and imaging firms such as Siemens Healthineers and GE Healthcare further impact market growth with their provision of advanced diagnostic instruments for exact identification of thyroid disorders. Partnerships between healthcare organizations and pharmaceutical companies have heightened competition, which resulted from a rising awareness of thyroid diseases and the vitality of early detection of said illness. Competition in this market is predicted to stay strong, fostering continuous breakthroughs in treatment options and diagnostic technology, as the frequency of thyroid problems rises globally.
Top Player’s Company Profiles
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the prospects of the global thyroid gland disorders treatment market appear promising, driven by increasing awareness, rising incidence of thyroid disorders, and advancements in treatment modalities. Innovative therapies, including precision medicine and targeted drug development, are expected to expand treatment options. Additionally, the integration of AI and telemedicine in healthcare may improve diagnostics and patient management. However, challenges such as regulatory hurdles and cost constraints must be addressed. Overall, the market is poised for growth, with a focus on personalized medicine and technology-driven solutions likely to shape its trajectory in the coming years.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 2.37 billion |
Market size value in 2031 | USD 3.14 billion |
Growth Rate | 3.17% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Thyroid Gland Disorders Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Thyroid Gland Disorders Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Thyroid Gland Disorders Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Thyroid Gland Disorders Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2083
sales@skyquestt.com
USA +1 351-333-4748